CENTRUM
Live / Registered — Registered (as of 22 Aug 2023)
What this means for you
Registered since 22 Aug 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 22 Aug 2029: the §8 declaration of use).
Record
- Serial number
- 90185447
- Registration number
- 7145961
- Mark type
- Design + words
- Filed
- 16 Sept 2020
- Published for opposition
- 06 Jul 2021
- Registered
- 22 Aug 2023
- Next maintenance filing
- §8 declaration of use, due by 22 Aug 2029 (grace period to 22 Feb 2030)
- Attorney of record
- Arrielle S. Siolos
Goods and services
- Class 005 — Pharmaceuticals: Dietary and nutritional supplements; vitamins
Owner
- HALEON US HOLDINGS LLC, WILMINGTON, DE, US
- GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, WILMINGTON, DE, US
- GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, WILMINGTON, DE, US
- GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, Wilmington, DE, US
Prior registrations
Prosecution history
- 07 Feb 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 22 Aug 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Aug 2023 — REGISTERED-PRINCIPAL REGISTER
- 18 Jul 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 Jul 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Jul 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Jul 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Jul 2023 — ASSIGNED TO LIE
- 08 Mar 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 Jan 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 30 Jan 2023 — NON-FINAL ACTION E-MAILED
- 30 Jan 2023 — SU - NON-FINAL ACTION - WRITTEN
- 10 Jan 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jan 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Dec 2022 — USE AMENDMENT FILED